Abstract:The sialyl Lewis X (SLex) antigen encoded by the FUT7 gene is the ligand of endotheliam-selectin (E-selectin). The combination of SLex antigen and E-selectin represents an important way for malignant tumor metastasis. In the present study, the effect of the SLex-binding DNA aptamer on the adhesion and metastasis of hepatocellular carcinoma HepG2 cells in vitro was investigated. Reverse transcription-polymerase chain reaction (RT-PCR) and immunofluorescence staining were conducted to detect the expression of FUT7 at both transcriptional and translational levels. The SLex expression in HepG2 cells treated with different concentrations of SLex-binding DNA aptamer was detected by flow cytometry. Besides, the adhesion, migration, and invasion of HepG2 cells were measured by cell adhesion assay, and the Transwell migration and invasion assay. The results showed that the FUT7 expression was up-regulated at both mRNA and protein levels in HepG2 cells. SLex-binding DNA aptamer could significantly decrease the expression of SLex in HepG2 cells. The cell adhesion assay revealed that the SLex-binding DNA aptamer could effectively inhibit the interactions between E-selectin and SLex in the HepG2 cells. Additionally, SLex-binding DNA aptamers at 20 nmol/L were found to have the similar effect to the monoclonal antibody CSLEX-1. The Transwell migration and invasion assay revealed that the number of penetrating cells on the down-side of Transwell membrane was significantly less in cells treated with 5, 10, 20 nmol/L SLex-binding DNA aptamer than those in the negative control group (P<0.01). Our study demonstrated that the SLex-binding DNA aptamer could significantly inhibit the in vitro adhesion, migration, and invasion of HepG2 cells, suggesting that the SLex-binding DNA aptamer may be used as a potential molecular targeted drug against metastatic hepatocellular carcinoma.

DNA Aptamer Blockade of Sialyl LewisX Inhibits Growth and Metastasis of HepG2 Hepatocellular Carcinoma Cells in Vitro

Inhibition of Adhesion and Metastasis of HepG2 Hepatocellular Carcinoma Cells in Vitro by DNA Aptamer Against Sialyl Lewis X

DNA aptamer against sialyl lewis X inhibits metastasis of breast cancer cells in vitro

Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic Potential.

Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.

Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated Via Cell-SELEX

Selection and verification of ssDNA aptamers to Sialyl LewisX by SELEX technique

In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.

The aptamers generated from HepG2 cells

[Effects of High Metastatic Potential Hepatocellular Carcinoma Cell-Binding Peptide on the Invasion and Metastasis of Liver Cancer].

Studies on sLe~(a/x) and Hematogenous Metastasis of Cancer

Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.

Targeted Delivery Of Chemotherapy Agents Using A Liver Cancer-Specific Aptamer

Evolution of Dna Aptamers Through in Vitro Metastatic-Cell-Based Systematic Evolution of Ligands by Exponential Enrichment for Metastatic Cancer Recognition and Imaging

Screening and Verification of Ssdna Aptamers Targeting Human Hepatocellular Carcinoma

Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib

Inhibitory effects of anti-adhesion peptides on invasion/metastasis ability of hepatocellular carcinoma cells

Development of a DNA Aptamer Against Multidrug-Resistant Hepatocellular Carcinoma for in Vivo Imaging.

The Effect of CXCR7/SDF-1 on the Proliferation, Migration,and Adhesion of the Hepatoma Cells

The Effect of Autocrine Motility Factor on the Invasion and Metastasis of Hepatocellular Carcinoma

α2,6-linked sialic acids on N-glycans modulate the adhesion of hepatocarcinoma cells to lymph nodes